IDENTIFICATION OF RECURRENT MUTATED NEOPEPTIDES
Abstract:
A method of treating cancer in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of T cells expressing a T cell receptor (TCR) having a CDR3 amino acid sequence selected from the group consisting of 199-210.
Information query
Patent Agency Ranking
0/0